Skip to content

Clinical trials

Phase 2/3 beta-Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Phase: Phase 2/3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20092
20123
20142
20182
20191
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ain Shams University4
Children's Hospital Karachi2
Al-Neelain University1
Beni-Suef University1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Isfahan University of Medical Sciences1
Novartis Pharmaceuticals1
Shiraz University of Medical Sciences1
Tehran University of Medical Sciences1
University of Campinas, Brazil1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia15
Iron Overload3
Anemia, Sickle Cell2
Thalassemia2
Genetic Diseases, Inborn1
Hematologic Diseases1
Hemoglobinopathies1
Hepatoblastoma1
Neoplasms1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.